Equities

GreenHy2 Ltd

H2G:ASX

GreenHy2 Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.004
  • Today's Change0.00 / 0.00%
  • Shares traded334.28k
  • 1 Year change-65.69%
  • Beta1.0830
Data delayed at least 20 minutes, as of Nov 14 2024 00:55 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year GreenHy2 Ltd had revenues fall -26.74% from 292.82k to 214.52k, though the company grew net income from a loss of 3.26m to a smaller loss of 1.75m.
Gross margin100.00%
Net profit margin-1,017.12%
Operating margin-1,012.17%
Return on assets-39.37%
Return on equity-44.57%
Return on investment-43.86%
More ▼

Cash flow in AUDView more

In 2023, cash reserves at GreenHy2 Ltd fell by 1.25m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 426.62k for operations while cash used for investing totalled 821.12k.
Cash flow per share-0.0032
Price/Cash flow per share--
Book value per share0.0056
Tangible book value per share0.0026
More ▼

Balance sheet in AUDView more

GreenHy2 Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio5.26
Quick ratio--
Total debt/total equity0.043
Total debt/total capital0.0412
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.